Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 9/20 | 0.42 |
| ▸ | NPY1R | P25929 | 5/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
| ▸ | Q9HBH1 | 1/20 | 0.35 | |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
| ▸ | NPY2R | P49146 | 3/20 | 0.34 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.33 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | TGM2 | P21980 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4552682 | 0.86 | FOLH1 (0.40) | NPY4RNPY1RFOLH1GRIA1NPY2R | |
| SCHEMBL1724846 | 0.86 | FOLH1 (0.40) | NPY4RNPY1RFOLH1GRIA1NPY2R | |
| SCHEMBL5807981 | 0.84 | NPY4R (0.44) | NPY4RNPY1RFOLH1PDFNPY2R | |
| SCHEMBL2390736 | 0.84 | NPY4R (0.44) | NPY4RNPY1RFOLH1PDFNPY2R | |
| SCHEMBL21879809 | 0.84 | NPY4R (0.44) | NPY4RNPY1RFOLH1PDFNPY2R | |
| SCHEMBL28672685 | 0.84 | MEN1 (0.47) | NPY4RNPY1RMEN1GAAKMT2A | |
| SCHEMBL21284538 | 0.84 | GRIA1 (0.33) | NPY4RNPY1RPDFGRIA1ERAP1 | |
| SCHEMBL5849013 | 0.84 | MEN1 (0.47) | NPY4RNPY1RMEN1GAAKMT2A | |
| Hydrochloric Acid SCHEMBL11506342 | 0.83 | NPY4R (0.44) | NPY4RNPY1RFOLH1PDFNPY2R | |
| Hydrochloric Acid SCHEMBL10870558 | 0.83 | MEN1 (0.46) | NPY4RNPY1RMEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4363433-B1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | AMICOAT AS (NO) | 2025-10-08 | — | — | EP | disclosed |
| US-20240174713-A1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | PHARMA HOLDINGS AS (NO) | 2024-05-30 | — | — | US | disclosed |
| WO-2023275410-A1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | AMICOAT AS (NO) | 2023-01-05 | — | — | WO | disclosed |
| US-10961202-B2 | Bis-benzimidazole compounds and methods of using the same | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-03-30 | — | — | US | disclosed |
| US-20190152924-A1 | BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING THE SAME | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2019-05-23 | — | — | US | disclosed |
| US-20170029381-A1 | TETRAHYDRO-BENZOIMIDAZOLYL MODULATORS OF TGR5 | JANSSEN PHARMACEUTICA NV (BE) | 2017-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10961202-B2 | Bis-benzimidazole compounds and methods of using the same | HNRNPH1, HNRNPH3, HNRNPUL2 | NPY4R 4703/4885NPY1R 4789/4885FOLH1 726/4885 |
| US-20240174713-A1 | PEPTIDE SYNTHESIS METHOD INVOLVING STERICALLY HINDERED MIXED ANHYDRIDE INTERMEDIATE | VIP, GRPR, SSTR4 | NPY4R 42/4885NPY1R 41/4885FOLH1 145/4885 |
| US-20190152924-A1 | BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING THE SAME | HNRNPH1, HNRNPH3, HNRNPUL2 | NPY4R 4703/4885NPY1R 4789/4885FOLH1 726/4885 |
| US-20170029381-A1 | TETRAHYDRO-BENZOIMIDAZOLYL MODULATORS OF TGR5 | GLRA1, GRM5, TRHR | NPY4R 34/4885NPY1R 21/4885FOLH1 3719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.